NCT07618897

Brief Summary

PJK (proximal junctional kyphosis) at the upper end of spinal fusions after surgical correction of adult spinal deformity is not uncommon. Two-thirds of cases are observed within the first 3 months after surgery and 80% within the first 18 months. PJK is consequently a common problem after surgery for adult spinal deformity, representing one of the most frequent complications following this kind of procedure. Although the first-line treatment of this event is conservative, surgery may be necessary in around 30-40% of cases. Revision surgery generally consists of extending the posterior spinal instrumentation. Prophylactic vertebroplasty has been proposed to reduce the risk of PJK and PJF, with promising results but with the limitation of reinforcing only the bony structures, with no action on the soft tissues. In this context, some authors have reported that the use of tethers, creating a transitional zone at the upper end of the construct between the fused and the non-instrumented spine, could reduce the occurrence of this complication (PJK). One of the hypotheses is that the use of a topping-off system results in a transitional zone reducing stresses at the junctional spine and may reduce the occurrence of both PJK and the need for reoperation. Compared with other topping-off systems, such as hooks, the surface of contact provided by the bands on the posterior arches is much greater and the primary stability much better. In addition, the risk of malposition is extremely low. The aim of this study is therefore to compare the occurrence of PJK and PJF in patients for whom tethers were implanted at the upper end of the instrumentation versus patients for whom no tether system was used. In a retrospective study conducted in the neurosurgery department of the HCL on 38 patients undergoing multilevel spine instrumentation with junctional tethers, PJK occurred in 8 of them (21%) after 24 months of follow-up.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
128

participants targeted

Target at P50-P75 for not_applicable

Timeline
48mo left

Started Jun 2026

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress3%
Jun 2026Jun 2030

First Submitted

Initial submission to the registry

May 13, 2026

Completed
19 days until next milestone

First Posted

Study publicly available on registry

June 1, 2026

Completed
21 days until next milestone

Study Start

First participant enrolled

June 22, 2026

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 22, 2030

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 22, 2030

Last Updated

June 1, 2026

Status Verified

May 1, 2026

Enrollment Period

4 years

First QC Date

May 13, 2026

Last Update Submit

May 28, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Sub-laminar and/or interspinous tethers efficacy to prevent PJK

    Percentage of patients with PJK during the first post-operative 24 months with PJK defined as : * a proximal junctional sagittal Cobb angle (PJA) between the lower endplate of uppermost instrumented vertebra (UIV) with screws and the upper endplate of 2 supra-adjacent vertebra ≥15 * a 15° delta between 24months post operative PJA and preoperative PJA These 2 parameters will be assessed by an independent committee using radiographic images preop and 24 months postop

    From enrollment to 24 months post-surgery

Secondary Outcomes (7)

  • Sub-laminar and/or interspinous tethers efficacy to prevent PJF

    From enrollment to 24 months post-surgery

  • Sub-laminar and/or interspinous tethers efficacy to prevent surgery revision

    From enrollment to 24 months post-surgery

  • Sub-laminar and/or interspinous tethers efficacy to prevent the level of disabilty

    From enrollment to 24 months post-surgery

  • Sub-laminar and/or interspinous tethers efficacy to prevent pain

    From enrollment to 24 months post-surgery

  • Sub-laminar and/or interspinous tethers efficacy to enhance quality of life

    From enrollment to 24 months post-surgery

  • +2 more secondary outcomes

Study Arms (2)

Patient instrumented with a tether

EXPERIMENTAL

Sub-laminar and/or interspinous tethers

Device: Tether strategy

Reference strategy

ACTIVE COMPARATOR

Standard surgery

Procedure: Reference

Interventions

During spine surgery sub-laminar or interspinous bands are utilized in combination with standard posterior rigid instrumentation (i.e. screws and metallic rods). They are typically implanted at the upper vertebral level, above the cranial screws, and then connected to the rods. Their implantation is based on standard surgical techniques for spine surgeons.

Patient instrumented with a tether
ReferencePROCEDURE

Patient will undergo the spine surgery as the standard of care, using only standard posterior rigid instrumentation (i.e. screws and metallic rods).

Reference strategy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient men and women older than 18
  • Patient indicated spinal posterior fusion and instrumentation with the upper end (UIV with screws) between T9 and L2 and the lower end between L5 and iliac
  • Constructs ≥4 levels (i.e., ≥4 discs included)
  • Patient able to signed a consent form
  • Patient able to fill a self-administered questionnaire
  • Patient affiliated to health care insurance (social security in France

You may not qualify if:

  • Allergy to metal
  • Cimentoplasty at the junctional zone (UIV, UIV+1 and/or UIV+2)
  • Bone metabolism disorders that potentially compromise the mechanical support expected from this type of implant.
  • Morbid obesity (BMI \> 40)
  • Patients with infection (in particularly osteomyelitis)
  • Cancer of lesss than 5 years or currently treated
  • Acute trauma
  • Immunodepression
  • Parkinson
  • Chronic inflammatory disease
  • Severe psychological disorders
  • Pregnancy or women breastfeeding
  • Inadequate tissue coverage of implant site,
  • Interference with other critical anatomical structures.
  • Patient not being able to understand the objectives of the study or refusing to comply with postoperative instructions
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital Pierre Wertheimer - Hospices Civils de Lyon, Service de Neurochirurgie - Chirurgie du Rachis et de la Moëlle Epinière

Lyon, 69394, France

Location

Study Officials

  • Cédric BARREY, Ph

    Hospices Civiles de Lyon

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 13, 2026

First Posted

June 1, 2026

Study Start

June 22, 2026

Primary Completion (Estimated)

June 22, 2030

Study Completion (Estimated)

June 22, 2030

Last Updated

June 1, 2026

Record last verified: 2026-05

Locations